77517-29-4

MSD 883 L 154883 dihydromevinolin dihydro-lovastatin 4a,5-Dihydro Lovastatin Lovastatin EP IMpurity E Lovastatin Related CoMpound A (S)-(1S,3S,4aR,7S,8S,8aS)-8-(2-((2R,4R) Lovastatin Impurity 5(Lovastatin EP Impurity E) Lovastatin Related Compound A (20 mg) (Dihydro-lovastatin) (S)-2-Methylbutyric acid [(1S)-1,2,3,4,4a,7,8,8aα-octahydro-3β,7α-dimethyl-8α-[2-[[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran]-2-yl]ethyl]naphthalen]-1β-yl ester (1S,3S,4aR,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H- pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naph thalenyl (2S)-2-methylbutanoate (2S)-2-Methylbutanoic Acid (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-Octahydro- 3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester Butanoic acid, 2-methyl-, (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)- Butanoic acid, 2-methyl-, 1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha (R*), 3-alpha, 4a-alpha, 7-beta, 8-beta (2S*